ASCO Metastatic Colorectal Cancer Guideline Pocket Guide - Guideline Central
Key Points
Treatment
logo_primary_text

Metastatic Colorectal Cancer

American Society of Clinical Oncology


Publication Date: October 17, 2022


Grading Table

Recommendation Grading

Recommendation Rating Definitions

Quality of Evidence

Strength of Recommendation

Brozek JL, Akl EA, Compalati E, et al: Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy 66:588-95, 2011

Abbreviations

ASCO
American Society of Clinical Oncology
CRS
cytoreductive surgery
CT
chemotherapy
dMMR
deficient mismatch repair
EGFR
epidermal growth factor receptor
EORTC
European Organisation for Research and Treatment of Cancer
FOLFIRI
folinic acid (leucovorin), fluorouracil, irinotecan
FOLFOX
folinic acid (leucovorin), fluorouracil, oxaliplatin
HIPEC
hyperthermic intraperitoneal chemotherapy
mCRC
metastatic colorectal cancer
MDT
multidisciplinary team
MSI-H
Microsatellite instability-high
MSS
microsatellite stable
pMMR
proficient DNA mismatch repair
SBRT
stereotactic body radiation therapy
sirt
selective internal radiation therapy
VEGF
vascular endothelial growth factor

Source Citation

Morris VK, Kennedy EB, Baxter NN, et al. Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 2022 Oct 17. doi: 10.1200/JCO.22.01690

Disclaimer

This pocket guide is derived from recommendations in the American Society of Clinical Oncology Guideline. This resource is a practice tool based on ASCO® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. The practice guidelines and additional information are available at www.asco.org/gastrointestinal-cancer-guidelines. Copyright © 2022 by American Society of Clinical Oncology. All rights reserved.

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.